Sesen Bio Profit Margin

The latest profit margin for SESN is -292.77% as of September 2025. That compares with -326.22% in the prior-year period — up 10.3% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Sesen Bio's historical trend and sector peers before judging valuation or financial health.

Over the past year, SESN's profit margin moved from -326.22% to -292.77% — a 10.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sesen Bio's valuation or profitability profile.

Against Healthcare companies, SESN currently prints -292.77% for profit margin, while the sector average sits near 13.89%. That is roughly 2207.3% below the sector mean. Large gaps often invite a closer look at Sesen Bio's growth, margins, and balance sheet.

Profit Margin shows how effectively Sesen Bio converts resources into returns. At -292.77%, SESN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -326.22% in the prior-year period — up 10.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SESN's profit margin (-292.77%), review year-over-year change from -326.22%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.